The pioneering AbiProt® technology is a completely new concept in antibody discovery. It has proven capabilities to deliver antibodies against clinically meaningful targets, previously undruggable with conventional antibody technologies. AbiProt® is a scalable breakthrough innovation with potential to impact the lives of millions of patients.

      About AbiProt®

      Making a difference for patients lacking treatment options

      We focus on developing new antibody medicines in pain and aggressive-metastatic cancer. These conditions are in strong need of effective therapies that can only be solved by breakthrough science and innovation. The AbiProt technology has proven to deliver precision mAbs against clinically meaningful targets in these two disease areas.

      About our Pipeline

      Committed to transform antibody therapeutics

      We are a team of pharma professionals and young talent with strong scientific and business acumen. We have a proven track record of bringing drugs to the market, and we have a proven track record of excellence in science and product development. We are devoted to change the life of patients through innovation.

      About our Team

      Highlighted programs in the pipeline

      Contact us